DE3784977D1 - Verwendung von adenosin-derivaten als anti-dementia-mittel. - Google Patents

Verwendung von adenosin-derivaten als anti-dementia-mittel.

Info

Publication number
DE3784977D1
DE3784977D1 DE8787105843T DE3784977T DE3784977D1 DE 3784977 D1 DE3784977 D1 DE 3784977D1 DE 8787105843 T DE8787105843 T DE 8787105843T DE 3784977 T DE3784977 T DE 3784977T DE 3784977 D1 DE3784977 D1 DE 3784977D1
Authority
DE
Germany
Prior art keywords
dementia
adenosine derivatives
adenosine
agent
dementia agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787105843T
Other languages
English (en)
Other versions
DE3784977T2 (de
Inventor
Masayoshi Goto
Nobutaka Nippon Hoechst Demura
Tsutomu Osaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Publication of DE3784977D1 publication Critical patent/DE3784977D1/de
Application granted granted Critical
Publication of DE3784977T2 publication Critical patent/DE3784977T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8787105843T 1986-04-25 1987-04-21 Verwendung von adenosin-derivaten als anti-dementia-mittel. Expired - Lifetime DE3784977T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61094738A JPH0696534B2 (ja) 1986-04-25 1986-04-25 抗痴呆剤

Publications (2)

Publication Number Publication Date
DE3784977D1 true DE3784977D1 (de) 1993-04-29
DE3784977T2 DE3784977T2 (de) 1993-08-05

Family

ID=14118453

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787105843T Expired - Lifetime DE3784977T2 (de) 1986-04-25 1987-04-21 Verwendung von adenosin-derivaten als anti-dementia-mittel.

Country Status (12)

Country Link
US (1) US5023244A (de)
EP (1) EP0253962B1 (de)
JP (1) JPH0696534B2 (de)
AT (1) ATE87209T1 (de)
AU (1) AU610822B2 (de)
CA (1) CA1287298C (de)
DE (1) DE3784977T2 (de)
DK (1) DK169656B1 (de)
IE (1) IE60886B1 (de)
IL (1) IL82298A0 (de)
PT (1) PT84765B (de)
ZA (1) ZA872879B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0723394B2 (ja) * 1986-11-27 1995-03-15 日本臓器製薬株式会社 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
EP0464206A4 (en) * 1989-03-24 1992-05-13 Daiichi Pharmaceutical Co., Ltd. Drug for improving brain function
US5206222A (en) * 1991-05-22 1993-04-27 Vanderbilt University Methods for the reduction of myocardial reperfusion injury
US5432164A (en) * 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
FR2685918B1 (fr) * 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2687678B1 (fr) * 1992-01-31 1995-03-31 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
DK62692D0 (de) * 1992-05-14 1992-05-14 Novo Nordisk As
DK62592D0 (de) * 1992-05-14 1992-05-14 Novo Nordisk As
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
YU81100A (sh) 1998-06-23 2003-10-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4 diola
AU2001273212A1 (en) 2000-07-07 2002-01-21 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030069203A1 (en) * 2001-06-04 2003-04-10 Lee Steve S. Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
AR049384A1 (es) 2004-05-24 2006-07-26 Glaxo Group Ltd Derivados de purina
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224438A (en) * 1970-07-14 1980-09-23 Boehringer Mannheim Gmbh Adenosine-5'-carboxylic acid amides
US4029884A (en) * 1971-03-18 1977-06-14 Abbott Laboratories Adenosine-5'-carboxylic acid amides
US3864483A (en) * 1972-03-22 1975-02-04 Abbott Lab Adenosine-5{40 -carboxylic acid amides
US3992531A (en) * 1973-12-26 1976-11-16 Abbott Laboratories 2-Substituted adenosine-5'-carboxylates in the treatment of anginal pain
LU73052A1 (de) * 1975-07-24 1977-03-24
DE2610985A1 (de) * 1976-03-16 1977-09-29 Byk Gulden Lomberg Chem Fab Arzneimittel enthaltend beta-d-1 (6-amino-9h-purin-9-yl)-1-deoxyribofuranuronsaeurederivate
LU75374A1 (de) * 1976-07-13 1978-02-08
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use

Also Published As

Publication number Publication date
DK209187D0 (da) 1987-04-24
IL82298A0 (en) 1987-10-30
IE871069L (en) 1987-10-25
AU7194687A (en) 1987-10-29
CA1287298C (en) 1991-08-06
JPH0696534B2 (ja) 1994-11-30
PT84765B (pt) 1989-12-29
AU610822B2 (en) 1991-05-30
DK209187A (da) 1987-10-26
DK169656B1 (da) 1995-01-09
ZA872879B (en) 1987-11-25
EP0253962A3 (en) 1988-11-30
PT84765A (en) 1987-05-01
US5023244A (en) 1991-06-11
JPS62252726A (ja) 1987-11-04
EP0253962A2 (de) 1988-01-27
EP0253962B1 (de) 1993-03-24
IE60886B1 (en) 1994-08-24
ATE87209T1 (de) 1993-04-15
DE3784977T2 (de) 1993-08-05

Similar Documents

Publication Publication Date Title
DE3784977D1 (de) Verwendung von adenosin-derivaten als anti-dementia-mittel.
DK172089D0 (da) 1,3-dioxolanderivater samt fremgangsmaade til fremstilling deraf
DE68901043D1 (de) Waessriges pharmazeutisches praeparat.
DK11992D0 (da) Epipodophyllotoxinglycosid-4'-phosphatderivater, deres fremstilling og anvendelse
LV10614A (lv) 2-anilinopirimidina atvasinajumi
IT8720059A0 (it) Process per la preparazione di (2,2)-paraciclofano e suoi derivati.
PT86660A (pt) Process for preparing adenosine 5:-carboxamide derivatives
DE3889302D1 (de) 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff.
DK131887D0 (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
DK23289A (da) Disubstituerede pyridinderivater, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
NO913686D0 (no) Fremgangsmaate for fremstilling av 9-substituerte guaninderivater og mellomprodukter for anvendelse i fremgangsmaaten.
IL84894A0 (en) Resolution of 1,4-dihydropyridine derivatives and optically active derivative salts of such derivatives
NO912545L (no) Nye 3,3'-ditiobis(propionsyrer) og estere derav samt fremgangsmaate for deres fremstilling
PT87550A (pt) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
HUT46839A (en) Herbicide compositions containing phenoxy-phenyl-thiourea-, isothiourea- and carbodiimide derivatives as active components and process for producing the active components
NZ233781A (en) (cyclic)phosphonyl-substituted guanine or adenine derivatives and pharmaceutical compositions
ATE111104T1 (de) Nukleosid-derivate.
IT8448415A0 (it) Derivati della 1,4-diidropiridina, loro preparazione e loro impiego come medicamenti
PT86771A (pt) Process for preparing 4-substituted benzamide derivatives with anticonvulsant activity
PT87705A (pt) Process for the preparation of 6-deoxy guanine derivative
DK587689D0 (da) 2-azabicyclo(2,2,1)hept-5-en-2-eddikesyre og derivater deraf, deres fremstilling og anvendelse
DE3888727D1 (de) Verwendung von Äthylamin-Derivaten als antihypertensive Wirkstoffe.
GR861529B (en) 1,4-dihydropyridine derivatives used for the treatment of cardiovascular diseases
FI890864A0 (fi) Anvaendning av 1,4-dihydropyridinderivat.
HU9202873D0 (en) 1,4-dihydropyridine derivatives of paf-antagonistic effect

Legal Events

Date Code Title Description
8364 No opposition during term of opposition